Skip to main content
Equibles

NVO · Novo Nordisk A S · Held by Funds

Track NVO — free

Use NVO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NVO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$37.54 -0.37 (-0.99%)
Rebalance outlook locked
Market Cap
$171.37B
Shares
4.42B
Volume · Oct 1 6.27M Avg daily vol (3M) 12.35M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Funds holding NVO

191 fund positions
Fund Balance Value % of Fund Open
Dodge & Cox Stock Fund 15,240,800 $730,643,952 0.62%
Putnam Large Cap Value Fund 7,975,159 $375,470,486 0.68%
Washington Mutual Investors Fund 5,338,458 $251,334,603 0.12%
Loomis Sayles Growth Fund 5,111,619 $245,051,015 1.49%
American Balanced Fund 4,750,000 $227,715,000 0.08%
T. Rowe Price International Stock Fund 2,639,421 $124,263,941 0.93%
Putnam Focused Large Cap Value ETF 2,039,666 $92,967,976 0.84%
T. Rowe Price Equity Income Fund 1,750,000 $83,895,000 0.47%
ALGER FOCUS EQUITY FUND 1,774,107 $83,524,958 1.17%
Amana Growth Fund 1,634,595 $74,504,840 1.10%
College Retirement Equities Fund - Total Global Stock Account 1,539,631 $73,809,910 0.05%
Dodge & Cox Balanced Fund 1,275,900 $61,166,646 0.41%
Bridge Builder Large Cap Value Fund 1,201,299 $57,590,274 0.20%
Avantis International Equity ETF 1,102,732 $50,262,525 0.30%
VanEck Pharmaceutical ETF 984,355 $47,189,979 5.37%
INTERNATIONAL CORE EQUITY 2 PORTFOLIO 928,818 $43,728,751 0.10%
Loomis Sayles Growth Portfolio 901,444 $43,215,225 1.49%
The Institutional U.S. Equity Portfolio 876,832 $42,035,326 1.32%
ALGER SPECTRA FUND 793,505 $37,358,215 0.87%
T. Rowe Price Health Sciences Fund, Inc. 752,169 $36,058,982 0.30%
First Trust WCM International Equity ETF 631,040 $30,252,058 1.84%
ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND 569,175 $26,796,759 0.78%
Simplify Health Care ETF 504,918 $24,205,769 6.75%
Multi-Manager Large Cap Growth Strategies Fund 456,677 $21,893,095 0.49%
Focused Appreciation Portfolio 448,804 $21,515,664 1.50%
Invesco International Dividend AchieversTM ETF 455,640 $21,451,531 2.32%
Nuveen Multi Cap Value Fund 445,522 $21,358,325 1.70%
ALGER CAPITAL APPRECIATION FUND 452,764 $21,316,129 0.78%
Disciplined Value Global Long/Short Fund 420,660 $20,166,440 1.56%
Putnam VT Large Cap Value Fund 414,754 $19,883,307 0.73%
Victory Growth Fund 380,424 $17,910,362 0.76%
abrdn World Healthcare Fund 367,740 $17,629,456 3.11%
Nuveen Dividend Value Fund 355,194 $16,722,534 0.48%
Strategic Advisers U.S. Total Stock Fund 321,014 $14,631,818 0.01%
Washington Mutual Investors Fund 303,343 $14,542,263 0.12%
Empower Large Cap Value Fund 273,741 $13,123,143 0.58%
Integrity Dividend Harvest Fund 270,000 $12,711,600 1.62%
EuroPac International Value Fund 260,000 $12,240,800 6.21%
EQ/Loomis Sayles Growth Portfolio 250,626 $12,015,010 1.49%
MassMutual Blue Chip Growth Fund 248,960 $11,935,142 0.64%
AST Large-Cap Value Portfolio 215,808 $10,345,836 0.26%
LargeCap Growth Fund I 218,464 $10,285,285 0.18%
AQE Core ETF 200,297 $9,602,238 1.67%
Value Portfolio 200,152 $9,595,287 0.75%
ActivePassive International Equity ETF 206,077 $9,392,990 0.90%
Domestic Equity Portfolio 192,963 $9,250,646 0.73%
Victory Pioneer Multi-Asset Income Fund 190,190 $8,954,145 0.09%
Port Street Quality Growth Fund 171,331 $8,213,608 5.23%
Alger Concentrated Equity ETF 165,556 $7,936,755 1.08%
Natixis U.S. Equity Opportunities Fund 157,167 $7,534,586 0.65%
Showing 1–50 of 191 positions
Key facts CIK 353278 CUSIP 670100205 13F (30d) 31 filings 18 filers Visit website Investor relations